Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer

International Journal of Cancer

Volumn 100, Issue 5, 2002, Pages 515-519

  Nagatsuka, Isao ^a   Yamada, Nobuya ^a   Shimizu, Sadatoshi ^a   Ohira, Masaichi ^a   Nishino, Hiroji ^a   Seki, Shuichi ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colon cancer; Cyclooxygenase 2; Cyclooxygenase 2 inhibitor; Liver metastasis; Matrix metalloproteinase

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; GELATIN; GELATINASE A; GROWTH FACTOR; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; TILMACOXIB; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE CONTROL; GENE OVEREXPRESSION; IN VITRO STUDY; LIVER METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN SECRETION; ZYMOGRAPHY;

ANIMALS; BENZENESULFONATES; CELL DIVISION; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; ISOENZYMES; LIVER NEOPLASMS; LYMPHOKINES; MATRIX METALLOPROTEINASES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; OXAZOLES; PLATELET-DERIVED GROWTH FACTOR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037055533     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10508     Document Type: Article

References (35)

1. Aspirin use and reduced risk of fatal colon cancer
2. Aspirin use and risk of fatal cancer
3. Aspirin and the risk of colorectal cancer in woman
4. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
5. Aspirin use and potential mechanism for colorectal cancer prevention
6. Expression of prostaglandin G/H synthase-1 and C2 protein in human colon cancer
7. Differential expression and regulation of cyclooxygenase-1 and C2 in two human breast cancer cell lines
8. Expression of cyclooxygenase-1 and C2 in human colorectal cancer
9. Cyclooxygenase regulates angiogenesis induced by colon cancer
10. Cyclooxygenases 1 and 2
11. Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): In vitro antiproliferative effects of a COX-2 inhibitor
12. Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers
13. Expression of cyclooxygenase-2 in human gastric carcinoma
14. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
15. Cyclooxygenase-2 expression in human esophageal carcinoma
16. A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human neck and squamous carcinoma cells
17. Inhibition of hematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522
18. Profile of JTE-522 as a human cyclooxygenase-2 inhibitor
19. Effects of JTE-522, a specific inhibitor of cyclooxygenase-2, on the recurrence of allergic inflammation in rats
20. Increased sialyl Lewis A expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line
21. In vivo and in vitro interactions between human colon carcinoma cells and hepatic stellate cells
22. The biology of platelet derived growth factor
23. Regulation of chemotaxis by the platelet-derived growth factor receptor-β
24. Signal transduction by the PDGF receptors
25. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases
26. Contribution of angiogenesis to the progression of colon cancer: Possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis
27. Organic osmolyte transport in quiescent and activated hepatic stellate cells (Ito cells)
28. Induction of cyclo-oxgenase-2 in human endothelial cells by SIN-1 in the absence of prostaglandin production
29. Dynamics of nuclear localization sites for COX-2 in vascular endothelial cells
30. Differential effects of hexoses and sucrose, and platelet-derived growth factor isoforms on cyclooxygenase-1 and C2 mRNA expression in kelotid, hypertrophic scar and granulation tissue fibroblasts
31. Cell cycle-dependent expression of cyclooxygenase-2 in human fibroblasts
32. Prostaglandins and cancer: A review of tumor initiation through tumor metastasis
33. COX-2 and colon cancer: Potential targets for chemoprevention
34. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis
35. Progress in cancer chemoprevention